Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular Dystrophy

NCT02245711 is registered in ClinicalTrials.gov with Neurogen Brain and Spine Institute as lead sponsor.

NCT NCT02245711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular Dystrophy
Lead sponsor
Neurogen Brain and Spine Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 2010
Completion date
June 30, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

limb girdle muscular dystrophy